Ann: Commencement of CVac Ovarian Cancer Treatmen, page-36

re: Ann: Commencement of CVac Ovarian Cancer ... Jason4, it's good to see that not too many holders are being spooked. The vast majority of the holders are holding on - and so they should.

IMO, Prima is currently one of the best stocks in the ASX, with huge potential.

They have:-
*a great product which is 13 years down the track of a typically 15 year commercialisation cycle.

*very importantly, the cash to proceed with the commercialisation cycle.

*excellent management with the vision to maximize shareholder return.

*an assembled specialist team which is second to none to proceed with the tasks ahead.

*a very highly regarded and internationally recognized advisory group.

Like Jason4, day to day price fluctuations matter little to me. It's the fundamentals which are important. For Prima, the fundamentals are excellent (plus), and I am therefore very confident that this will be reflected in the sp in the not too distant future.